Predicted protein targets (top 9)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.38 |
| ▸ | TSHR | P16473 | 3/20 | 0.38 |
| ▸ | LMNA | P02545 | 2/20 | 0.33 |
| ▸ | MEN1 | O00255 | 1/20 | 0.33 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.33 |
| ▸ | ADRB3 | P13945 | 1/20 | 0.33 |
| ▸ | FDPS | P14324 | 1/20 | 0.33 |
| ▸ | PDE4D | Q08499 | 1/20 | 0.33 |
| ▸ | PDE3A | Q14432 | 1/20 | 0.33 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL349072 | 0.82 | ALDH1A1 (0.30) | ALDH1A1TSHR | |
| SCHEMBL14655732 | 0.80 | FDPS (0.39) | ALDH1A1TSHRLMNAFDPSPDE3A | |
| SCHEMBL15800756 | 0.80 | ALDH1A1 (0.35) | ALDH1A1TSHR | |
| SCHEMBL2362566 | 0.78 | NFKB1 (0.41) | ALDH1A1TSHRLMNAMEN1KMT2A | |
| Ethylenediamine SCHEMBL4806171 | 0.77 | ALDH1A1 (0.43) | ALDH1A1TSHRLMNAMEN1KMT2A | |
| SCHEMBL5399410 | 0.76 | LMNA (0.33) | ALDH1A1LMNAMEN1KMT2AADRB3 | |
| SCHEMBL1351936 | 0.76 | ALDH1A1 (0.44) | ALDH1A1TSHRLMNAADRB3FDPS | |
| SCHEMBL15964473 | 0.76 | FDPS (0.33) | FDPS | |
| Hydrochloric Acid SCHEMBL7207058 | 0.76 | FDPS (0.39) | ALDH1A1TSHRLMNAFDPSPDE3A | |
| Monoethanolamine SCHEMBL28077753 | 0.74 | ALDH1A1 (0.61) | ALDH1A1TSHRLMNAMEN1KMT2A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 103 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-3911795-B1 | METHOD OF STRENGTHENING NON-KERATINOUS FIBERS, AND USES THEREOF | ISP INVESTMENTS LLC (US) | 2025-10-01 | — | — | EP | claimed |
| CN-113646479-B | Method for strengthening non-keratin fibers and use thereof | 埃斯普投资有限公司 | 2023-06-13 | — | — | CN | claimed |
| CN-115927286-A | Immobilized spirulina platensis algae bead and preparation method and application thereof | 揭阳职业技术学院 | 2023-04-07 | — | — | CN | claimed |
| CN-114699934-B | Separation membrane material, preparation method and application | 天津海龙津阳材料科技有限公司 | 2022-09-06 | — | — | CN | claimed |
| CN-114699934-A | Separation membrane material, preparation method and application | 天津海龙津阳材料科技有限公司 | 2022-07-05 | — | — | CN | claimed |
| EP-3565523-B1 | METHOD FOR COLORING OR BLEACHING HAIR FIBERS | HERCULES LLC (US) | 2021-09-08 | — | — | EP | claimed |
| EP-2688554-A2 | OPTIMISED PREPARATIONS OF HIGHLY ADAPTABLE AGGREGATES | Cevc, Gregor (DE) | 2014-01-29 | — | — | EP | claimed |
| US-20130011466-A1 | LIPOSOME ENCAPSULATING AMMINE-PLATINUM COMPLEX AT HIGH CONCENTRATION, AND METHOD FOR PRODUCTION OF THE LIPOSOME | KATAYAMA CHEMICAL INDUSTRIES CO., LTD. (JP) | 2013-01-10 | — | — | US | claimed |
| WO-2012126966-A2 | OPTIMISED PREPARATIONS OF HIGHLY ADAPTABLE AGGREGATES | CEVC GREGOR (DE) | 2012-09-27 | — | — | WO | claimed |
| US-20090169610-A1 | Liposome Preparation | SIEMENS AKTIENGESELLSCHAFT (DE) | 2009-07-02 | — | — | US | claimed |
| EP-1980243-A1 | LIPOSOME PREPARATION | Takeda Pharmaceutical Company Limited (JP) | 2008-10-15 | — | — | EP | claimed |
| US-20070286896-A1 | Therapeutic or Diagnostic Drug for Inflammatory Disease Comprising Targeting Liposome | NATIONAL INSTITUTE OF ADVANCED INDUSTRIAL SCIENCE AND TECHNOLOGY | 2007-12-13 | — | — | US | claimed |
| US-20070160657-A1 | Targeting and intestinal-absorption controlled liposome having sugar chain and therapeutic drug for cancer and diagnostic drug containing the liposome | NATIONAL INSTITUTE OF ADVANCED INDUSTRIAL SCIENCE (JP) | 2007-07-12 | — | — | US | claimed |
| US-20060193906-A1 | Sugar-modified liposome and products comprising the liposome | NATIONAL INSTITUTE OF ADVANCED INDUSTRIAL SCIENCE AND TECHNOLOGY | 2006-08-31 | — | — | US | claimed |
| EP-1655038-A1 | TARGET-DIRECTED AND ENTERIC ABSORPTION-CONTROLLED LIPOSOME HAVING SUGAR CHAIN AND CANCER REMEDY AND DIAGNOSTIC CONTAINING THE SAME | National Institute of Advanced Industrial Science and Technology (JP) | 2006-05-10 | — | — | EP | claimed |
| EP-1655022-A1 | REMEDY OR DIAGNOSTIC FOR INFLAMMATORY DISEASE CONTAINING TARGET-DIRECTING LIPOSOME | National Institute of Advanced Industrial Science and Technology (JP) | 2006-05-10 | — | — | EP | claimed |
| EP-0098135-B1 | SOLUBILIZED PLATINUM(II) COMPLEXES | ENGELHARD CORPORATION (US) | 1986-04-30 | — | — | EP | claimed |
| EP-0098135-A2 | Solubilized platinum(II) complexes | ENGELHARD CORPORATION (US) | 1984-01-11 | — | — | EP | claimed |
| CN-113646479-B | Method for strengthening non-keratin fibers and use thereof | 埃斯普投资有限公司 | 2023-06-13 | — | — | CN | disclosed |
| EP-0136582-A2 | Developer compositions for silver halide photographic materials | MINNESOTA MINING AND MANUFACTURING COMPANY (US) | 1985-04-10 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20130011466-A1 | LIPOSOME ENCAPSULATING AMMINE-PLATINUM COMPLEX AT HIGH CONCENTRATION, AND METHOD FOR PRODUCTION OF THE LIPOSOME | SLC7A1, MLEC, PHOSPHO1 | ALDH1A1 3725/4885TSHR 3243/4885LMNA 1074/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.